MX2016012591A - Nuevo uso de n,n- bis-2-mercaptoetil isoftalamida. - Google Patents
Nuevo uso de n,n- bis-2-mercaptoetil isoftalamida.Info
- Publication number
- MX2016012591A MX2016012591A MX2016012591A MX2016012591A MX2016012591A MX 2016012591 A MX2016012591 A MX 2016012591A MX 2016012591 A MX2016012591 A MX 2016012591A MX 2016012591 A MX2016012591 A MX 2016012591A MX 2016012591 A MX2016012591 A MX 2016012591A
- Authority
- MX
- Mexico
- Prior art keywords
- bis
- new use
- mercaptoethyl isophthalamide
- isophthalamide
- mercaptoethyl
- Prior art date
Links
- QZUPTXGVPYNUIT-UHFFFAOYSA-N isophthalamide Chemical compound NC(=O)C1=CC=CC(C(N)=O)=C1 QZUPTXGVPYNUIT-UHFFFAOYSA-N 0.000 title abstract 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
- 229940072107 ascorbate Drugs 0.000 abstract 1
- 235000010323 ascorbic acid Nutrition 0.000 abstract 1
- 239000011668 ascorbic acid Substances 0.000 abstract 1
- 230000001172 regenerating effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
De acuerdo con la invención, se proporciona N,N-bis-2-mercaptoetil isoftalamida, o una sal o derivado farmacéuticamente aceptable de la misma, para su uso en la regeneración de ascorbato sistémicamente y, por lo tanto, en el tratamiento terapéutico de la enfermedad pulmonar obstructiva crónica. Figura 1.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1406115.4A GB2524831A (en) | 2014-04-04 | 2014-04-04 | New pharmaceutical use |
| PCT/GB2015/050999 WO2015150793A1 (en) | 2014-04-04 | 2015-03-31 | New use of n,n-bis-2-mercaptoethyl isophthalamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2016012591A true MX2016012591A (es) | 2017-04-06 |
Family
ID=50776843
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016012591A MX2016012591A (es) | 2014-04-04 | 2015-03-31 | Nuevo uso de n,n- bis-2-mercaptoetil isoftalamida. |
Country Status (36)
| Country | Link |
|---|---|
| US (1) | US9782368B2 (es) |
| EP (1) | EP3125876B8 (es) |
| JP (1) | JP6474423B2 (es) |
| KR (1) | KR102482699B1 (es) |
| CN (1) | CN106132405B (es) |
| AU (1) | AU2015242374B2 (es) |
| BR (1) | BR112016022880B1 (es) |
| CA (1) | CA2944113C (es) |
| CL (1) | CL2016002499A1 (es) |
| CY (1) | CY1121235T1 (es) |
| DK (1) | DK3125876T3 (es) |
| EA (1) | EA032116B1 (es) |
| EC (1) | ECSP16078100A (es) |
| ES (1) | ES2659174T3 (es) |
| GB (1) | GB2524831A (es) |
| HR (1) | HRP20180325T1 (es) |
| HU (1) | HUE036206T2 (es) |
| IL (1) | IL248027B (es) |
| LT (1) | LT3125876T (es) |
| MA (1) | MA39833B1 (es) |
| ME (1) | ME03012B (es) |
| MX (1) | MX2016012591A (es) |
| NO (1) | NO3125876T3 (es) |
| NZ (1) | NZ724678A (es) |
| PE (1) | PE20170586A1 (es) |
| PH (1) | PH12016501975A1 (es) |
| PL (1) | PL3125876T3 (es) |
| PT (1) | PT3125876T (es) |
| RS (1) | RS56905B1 (es) |
| SA (1) | SA516371966B1 (es) |
| SG (1) | SG11201607478RA (es) |
| SI (1) | SI3125876T1 (es) |
| SM (1) | SMT201800116T1 (es) |
| UA (1) | UA119558C2 (es) |
| WO (1) | WO2015150793A1 (es) |
| ZA (1) | ZA201606406B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202005057D0 (en) * | 2020-04-06 | 2020-05-20 | Emeramed Ltd | New Use |
| CN114778234B (zh) * | 2022-03-18 | 2025-08-15 | 武汉新烽光电股份有限公司 | 一种用于微流控总磷测试的抗坏血酸溶液的保存方法及保存结构 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6586600B2 (en) * | 2000-12-06 | 2003-07-01 | University Of Kentucky Research Foundation | Multidentate sulfur-containing ligands |
| JP2011026204A (ja) * | 2007-11-26 | 2011-02-10 | Rei Furukawa | タバコの煙を吸入することにより引き起こされる疾患の予防及び／又は治療用組成物 |
| US8950583B2 (en) * | 2008-12-06 | 2015-02-10 | Ermes Medical Company Limited | Method to remove heavy metals from a mammal |
| WO2011038385A2 (en) | 2009-09-28 | 2011-03-31 | University Of Kentucky Research Foundation | Thiol-containing compounds for the removal of elements from contaminated milieu and methods of use |
| US8575218B2 (en) | 2009-09-28 | 2013-11-05 | The University Of Kentucky Research Foundation | Thiol-containing compounds for the removal of elements from tissues and formulations therefor |
| US20110237776A1 (en) | 2010-03-25 | 2011-09-29 | Haley Boyd E | Aromatic compounds with sulfur containing ligands |
| US8426368B2 (en) * | 2010-03-25 | 2013-04-23 | The University Of Kentucky Research Foundation | Method of ameliorating oxidative stress and supplementing the diet |
-
2014
- 2014-04-04 GB GB1406115.4A patent/GB2524831A/en not_active Withdrawn
-
2015
- 2015-03-31 PT PT157235466T patent/PT3125876T/pt unknown
- 2015-03-31 DK DK15723546.6T patent/DK3125876T3/en active
- 2015-03-31 NZ NZ724678A patent/NZ724678A/en unknown
- 2015-03-31 HR HRP20180325TT patent/HRP20180325T1/hr unknown
- 2015-03-31 WO PCT/GB2015/050999 patent/WO2015150793A1/en not_active Ceased
- 2015-03-31 RS RS20180210A patent/RS56905B1/sr unknown
- 2015-03-31 SI SI201530158T patent/SI3125876T1/en unknown
- 2015-03-31 ME MEP-2018-50A patent/ME03012B/me unknown
- 2015-03-31 EA EA201692013A patent/EA032116B1/ru unknown
- 2015-03-31 JP JP2016557313A patent/JP6474423B2/ja active Active
- 2015-03-31 PL PL15723546T patent/PL3125876T3/pl unknown
- 2015-03-31 KR KR1020167030801A patent/KR102482699B1/ko active Active
- 2015-03-31 UA UAA201611073A patent/UA119558C2/uk unknown
- 2015-03-31 SG SG11201607478RA patent/SG11201607478RA/en unknown
- 2015-03-31 CN CN201580017210.4A patent/CN106132405B/zh active Active
- 2015-03-31 MX MX2016012591A patent/MX2016012591A/es active IP Right Grant
- 2015-03-31 US US15/129,654 patent/US9782368B2/en active Active
- 2015-03-31 EP EP15723546.6A patent/EP3125876B8/en active Active
- 2015-03-31 LT LTEP15723546.6T patent/LT3125876T/lt unknown
- 2015-03-31 BR BR112016022880-4A patent/BR112016022880B1/pt active IP Right Grant
- 2015-03-31 NO NO15723546A patent/NO3125876T3/no unknown
- 2015-03-31 CA CA2944113A patent/CA2944113C/en active Active
- 2015-03-31 PE PE2016001785A patent/PE20170586A1/es unknown
- 2015-03-31 MA MA39833A patent/MA39833B1/fr unknown
- 2015-03-31 HU HUE15723546A patent/HUE036206T2/hu unknown
- 2015-03-31 ES ES15723546.6T patent/ES2659174T3/es active Active
- 2015-03-31 SM SM20180116T patent/SMT201800116T1/it unknown
- 2015-03-31 AU AU2015242374A patent/AU2015242374B2/en active Active
-
2016
- 2016-09-16 ZA ZA2016/06406A patent/ZA201606406B/en unknown
- 2016-09-25 IL IL248027A patent/IL248027B/en active IP Right Grant
- 2016-09-30 EC ECIEPI201678100A patent/ECSP16078100A/es unknown
- 2016-09-30 CL CL2016002499A patent/CL2016002499A1/es unknown
- 2016-10-01 SA SA516371966A patent/SA516371966B1/ar unknown
- 2016-10-04 PH PH12016501975A patent/PH12016501975A1/en unknown
-
2018
- 2018-02-09 CY CY20181100160T patent/CY1121235T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX387115B (es) | Métodos para tratar la influenza. | |
| JP2016515522A5 (es) | ||
| MD3416631T2 (ro) | Agenți terapeutici pentru bolile neurodegenerative | |
| MX2022007989A (es) | Composiciones y metodos para tratar pterigion. | |
| MY199131A (en) | Human plasma kallikrein inhibitors | |
| IL240931A0 (en) | History 3 - Phenylpropylamine is converted to the treatment of eye diseases and disorders | |
| HK1245078A1 (zh) | 治疗神经退行性疾病的方法 | |
| EA201691481A1 (ru) | ИНГИБИТОРЫ C5a ДЛЯ ЛЕЧЕНИЯ ВИРУСНОЙ ПНЕВМОНИИ | |
| EA201690513A1 (ru) | Комбинация ингибитора mek и ингибитора erk для применения в лечении гиперпролиферативных заболеваний | |
| MA39710A (fr) | Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin | |
| EA201692111A1 (ru) | Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний | |
| EA201691656A2 (ru) | Терапевтические способы с применением норибогаина и родственных соединений | |
| IL256329B (en) | Carbazole derivatives for the treatment of fibrotic diseases, symptoms and conditions related to them | |
| UA118474C2 (uk) | (s)-пірліндол та його фармацевтично прийнятні солі для застосування в медицині | |
| PH12016501975A1 (en) | New use of n,n-bis-2-mercaptoethyl isophthalamide | |
| ZA201802399B (en) | Aminothiolester compounds or pharmaceutically acceptable salts thereof, for use in the treatment of cancer | |
| PH12017501955A1 (en) | Tetrahydrofurane-fused aminohydrothiazine derivatives which are useful in the treatment of alzheimer`s disease | |
| UA116499C2 (uk) | (r)-пірліндол та його фармацевтично прийнятні солі для застосування в медицині | |
| JO3609B1 (ar) | علاج الأعراض المرتبطة بالعلاج بالحرمان من الأندروجين | |
| NZ747201A (en) | (+)-azasetron for use in the treatment of ear disorders | |
| DK3148588T3 (en) | N,n-bis-2-mercaptoethyl isophthalamide for the treatment of parkinson's disease | |
| ITUB20153076A1 (it) | Composti farmaceuticamente attivi per l?impiego nel trattamento terapeutico di disturbi del movimento. | |
| PH12015502305A1 (en) | Use of pidotimod to treat inflammatory bowel disease | |
| PH12018500221A1 (en) | A prolonged release dosage form comprising oxycodone or a pharmaceutically acceptable salt thereof and naloxone or a pharmaceutically acceptable salt thereof in the treatment of bladder pain syndrome (bps) | |
| MX2016010919A (es) | 4-bencilsulfonil-2-butenonitrilo. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |